Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 21, 2020
Vectura Group announced an expansion of its capabilities to handle and develop HPAPIs at its facility in Chippenham, U.K.
read more
Friday, December 18, 2020
BD announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes.
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Thursday, December 17, 2020
Aeterna Zentaris has entered into a licensing agreement with Consilient Health for the commercialization in Europe and the United Kingdom of macimorelin.
read more
Wednesday, December 16, 2020
Sterling Pharma has announced a new strategic partnership with ADC Bio, a UK based biotechnology company specializing in antibody drug conjugates.
read more
Wednesday, December 16, 2020
Mesquite, TX MPM Medical is voluntarily recalling one lot of Regenecare HA Hydrogel to the consumer level.
read more
Tuesday, December 15, 2020
Bora announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Monday, December 14, 2020
FUJIFILM Irvine Scientific has announced the launch of Sterile Express Media Service (SEMS), for small-scale, rapid production of non-GMP media tested for sterility.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Friday, December 11, 2020
Passage Bio and Catalent announced manufacturing operations have commenced to support AAV production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
read more
Thursday, December 10, 2020
Lonza has announced an investment to expand its particle engineering and drug product capabilities at its Oregon site.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Wednesday, December 09, 2020
Vectura has signed a global license and development agreement with Kinaset for VR588, a preclinical novel inhaled pan-JAK inhibitor for prevention and treatment of severe asthma.
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more